U.S. market Closed. Opens in 1 day 12 hours 43 minutes

PRTG | Portage Biotech Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue54.00K1.00KN/AN/AN/A
Gross Profit-54.00K-1.00KN/AN/AN/A
Operating Expenses18.20M16.58M15.59M12.44M5.98M
Selling, General & Admin5.66M8.36M8.82M5.13M1.87M
Research & Development12.54M8.21M6.77M7.31M4.11M
Other Operating ExpensesN/AN/AN/A-1.26MN/A
Operating Income-18.25M-16.57M-15.59M-12.44M-5.98M
Other Expenses / Income-67.44M-105.95M771.00K-2.45M-549.00K
Before Tax Income-85.70M-122.52M-14.82M-14.89M-5.08M
Income Tax Expenses-10.55M-17.86M4.35M2.30M2.17M
Net Income-75.34M-104.61M-19.17M-17.19M-7.25M
Interest Expenses32.00K9.00K43.00K177.00K557.00K
Basic Shares Outstanding20.34M16.12M13.06M11.73M10.95M
Diluted Shares Outstanding20.34M16.12M13.06M11.73M10.95M
EBITDA-18.20M-15.78MN/AN/AN/A
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-85.86M-122.46M-14.77M-14.71M-4.53M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙